Intravenous Infusion Pumps Market (By Product: Infusion pumps; By Disease Indication: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Intravenous Infusion Pumps Market, By Product

7.1.  Intravenous Infusion Pumps Market, by Product, 2021-2030

7.1.1.    Infusion pumps

7.1.1.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Intravenous Infusion Pumps Market, By Disease Indication

8.1.  Intravenous Infusion Pumps Market, by Disease Indication, 2021-2030

8.1.1.    Chemotherapy

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Diabetes

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Gastroenterology

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Analgesia/Pain Management

8.1.4.1.        Market Revenue and Forecast (2016-2030)

8.1.5.    Pediatrics/Neonatology

8.1.5.1.        Market Revenue and Forecast (2016-2030)

8.1.6.    Hematology

8.1.6.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Intravenous Infusion Pumps Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2016-2030)

9.1.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2016-2030)

9.2.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2016-2030)

9.3.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2016-2030)

9.4.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Product (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2016-2030)

9.5.2.    Market Revenue and Forecast, by Disease Indication (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Product (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by Disease Indication (2016-2030)

Chapter 10.  Company Profiles

10.1.              Baxter International

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              B. Braun Melsungen AG

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Medtronic

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Micrel Medical Devices SA

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Boston Scientific Corporation

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              CareFusion Corporation

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Fresenius Kabi

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Smiths Medical

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms